Metabolic Disorders

Metabolic disorders, while primarily endocrine in nature, can have significant psychiatric implications. From mood disturbances due to thyroid disorders to cognitive challenges in diabetes, understanding the broader impact is vital. The Journal of Clinical Psychiatry provides insights into the psychiatric aspects of metabolic disorders, emphasizing evidence-based therapeutic approaches. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care.

Recently published article about Metabolic Disorders

JCP
Metabolic Syndrome in Offspring of Bipolar Parents

July 1, 2024

In offspring of parents with bipolar disorder, lower socioeconomic status and personal history of mood disorders were associated with greater risk of metabolic syndrome and its components.
JCP
Diabetic medications and major congenital malformations

March 11, 2024

Diabetes is prevalent and poses risks to both mother and child during pregnancy. Evidence shows that diabetes is best treated during pregnancy, with insulin a first-line treatment and metformin...
PCC
Substance Abuse and Metabolic Syndrome

August 9, 2022

This study estimated the prevalence and predictors of metabolic syndrome among substance users in North India.
JCP
Daily Dose Effects of Risperidone on Metabolic Parameters

May 9, 2022

This study investigated whether dose is a factor in the development of metabolic side effects with atypical antipsychotics.
PCC

September 9, 2021

Weight gain and increased risk of hyperglycemia have been associated with the use of antidepressant medications. Could GLP-1 analogs or SGLT-2 inhibitors be beneficial for glycemic and weight control...
PCC

May 27, 2021

Do younger adult patients with hypertensive intracerebral hemorrhage have higher prevalence of comorbidities such as diabetes and worse clinical outcomes in comparison to older patients with this condition? Read...

Recent JCP Articles on Metabolic Disorders

JCP

March 20, 2018

Recent studies aimed at the development of personalized pharmacotherapy have identified CYP enzymes and transporters as important determinants of variability in drug disposition and response. Along these lines, this...
JCP

October 3, 2017

Identification of physiologic biomarker precursors that result from prolonged psychological stress allows for possible prevention of negative outcomes; however, long-term data on the association of trauma with such biomarkers...
JCP

January 25, 2017

Want to improve your strategy for treating older depressed patients with metabolic syndrome?  Read this article to see how particular cardiovascular risk factors contribute to a chronic course.

Recent PCC Articles on Metabolic Disorders

PCC

April 6, 2017

The struggle to identify patients most at risk for metabolic complications of antipsychotic use is ongoing. The authors of this study identified potential correlations between baseline plasma insulin level...
PCC

May 5, 2016

Can psychology interventions that cultivate positive states, such as feeling hopeful, grateful, and happy, lead to healthier behaviors in patients with chronic medical illness? To find out, the authors...
PCC

January 28, 2016

Many mental disorders may have a bidirectional relationship with metabolic syndrome, but metabolic screening is rare for affected patients. Can mandatory screening and electronic notification affect and improve this...

Featured Metabolic Disorders Research

JCP

January 17, 2017

The shorter life expectancy in patients with psychotic disorders is largely due to an increased risk of obesity, diabetes, and cardiovascular disease. This comparison of youths with first-episode psychosis...
JCP

November 23, 2016

Metformin is emerging as an important option for preventing or treating weight gain, type 2 diabetes, and metabolic syndrome in psychiatric patients. Here, Dr Andrade outlines the safety issues...
JCP

October 26, 2016

Children and adolescents treated with antipsychotics are at increased risk of weight gain and metabolic dysregulation. In this month's Clinical and Practical Psychopharmacology column, Chittaranjan Andrade looks at the...
PCC

April 2, 2020

Depression has been associated with high mortality in people with diabetes. This study assessed the prevalence and associated factors of depression among diabetic outpatients in Ethiopia.
JCP

March 31, 2020

Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in...
JCP

March 24, 2020

How soon is too soon to look for metabolic syndrome in your patients with schizophrenia? This randomized open-label trial investigates 7 risk factors of 5 atypical and 2 typical...
PCC

October 10, 2019

Vitamin B12 deficiency is associated with various psychiatric symptoms. This study assessed the pattern of serum folate and vitamin B12 levels in psychiatric inpatients compared to nonpsychiatric controls in...
JCP

August 6, 2019

Abnormal thyroid hormone levels are among the most common nonpsychiatric causes of mood and anxiety symptoms. This retrospective study examines the extent of the issue in youth with mood...
JCP

April 17, 2018

How does a patient's resilience level and history of childhood adversity impact his or her health? This study evaluated 114 schizophrenia patients and 101 comparison subjects to determine the...

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe now